RS66787B1 - Uređaj za lečenje anafilakse - Google Patents

Uređaj za lečenje anafilakse

Info

Publication number
RS66787B1
RS66787B1 RS20250407A RSP20250407A RS66787B1 RS 66787 B1 RS66787 B1 RS 66787B1 RS 20250407 A RS20250407 A RS 20250407A RS P20250407 A RSP20250407 A RS P20250407A RS 66787 B1 RS66787 B1 RS 66787B1
Authority
RS
Serbia
Prior art keywords
epinephrine
formulation
api
metered dose
dose
Prior art date
Application number
RS20250407A
Other languages
English (en)
Serbian (sr)
Inventor
George Harry Luciuk
Andrew Robert Martin
Conor Aidan Ruzycki
Warren Hugh Finlay
Original Assignee
Kokua Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kokua Pharma Inc filed Critical Kokua Pharma Inc
Publication of RS66787B1 publication Critical patent/RS66787B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • A61M11/003Particle size control by passing the aerosol trough sieves or filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00Acyclic saturated compounds containing halogen atoms
    • C07C19/08Acyclic saturated compounds containing halogen atoms containing fluorine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/02Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Processing Of Meat And Fish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20250407A 2021-03-23 2022-03-23 Uređaj za lečenje anafilakse RS66787B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
EP22716648.5A EP4188332B1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Publications (1)

Publication Number Publication Date
RS66787B1 true RS66787B1 (sr) 2025-06-30

Family

ID=81307871

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20250407A RS66787B1 (sr) 2021-03-23 2022-03-23 Uređaj za lečenje anafilakse

Country Status (20)

Country Link
US (1) US20220331237A1 (https=)
EP (2) EP4188332B1 (https=)
JP (1) JP2024515446A (https=)
KR (1) KR20230165764A (https=)
CN (1) CN117083054A (https=)
AU (1) AU2022245300B2 (https=)
BR (1) BR112023019156A2 (https=)
CA (1) CA3212189A1 (https=)
DK (1) DK4188332T3 (https=)
ES (1) ES3025005T3 (https=)
FI (1) FI4188332T3 (https=)
HR (1) HRP20250566T1 (https=)
HU (1) HUE071185T2 (https=)
IL (1) IL305534A (https=)
LT (1) LT4188332T (https=)
PL (1) PL4188332T3 (https=)
PT (1) PT4188332T (https=)
RS (1) RS66787B1 (https=)
SI (1) SI4188332T1 (https=)
WO (1) WO2022204328A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12514995B2 (en) * 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
SI1531794T1 (sl) 2002-06-28 2017-12-29 Civitas Therapeteutics, Inc. Epinefrin za vdihavanje
US7954491B2 (en) * 2003-06-13 2011-06-07 Civitas Therapeutics, Inc. Low dose pharmaceutical powders for inhalations
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US8367734B1 (en) * 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
PT2627386E (pt) * 2010-10-12 2015-06-11 Ivax Pharmaceuticals Ireland Dispositivo de pulverização nasal
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
KR20150048727A (ko) * 2012-08-29 2015-05-07 키에시 파르마슈티시 엣스. 피. 에이. 에어로졸 흡입 장치
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities

Also Published As

Publication number Publication date
EP4188332B1 (en) 2025-02-12
WO2022204328A1 (en) 2022-09-29
PT4188332T (pt) 2025-04-17
BR112023019156A2 (pt) 2023-10-17
HUE071185T2 (hu) 2025-08-28
LT4188332T (lt) 2025-05-12
US20220331237A1 (en) 2022-10-20
FI4188332T3 (fi) 2025-05-06
ES3025005T3 (en) 2025-06-05
JP2024515446A (ja) 2024-04-10
CN117083054A (zh) 2023-11-17
SI4188332T1 (sl) 2025-07-31
KR20230165764A (ko) 2023-12-05
AU2022245300B2 (en) 2026-04-02
CA3212189A1 (en) 2022-09-29
EP4188332A1 (en) 2023-06-07
DK4188332T3 (da) 2025-05-05
AU2022245300A1 (en) 2023-09-14
EP4545122A2 (en) 2025-04-30
PL4188332T3 (pl) 2025-11-24
HRP20250566T1 (hr) 2025-06-20
EP4545122A3 (en) 2025-05-07
IL305534A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
RS66787B1 (sr) Uređaj za lečenje anafilakse
JP7621220B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
US12491325B2 (en) Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity
ES2779273T3 (es) Formulación superfina de formoterol
KR20240042436A (ko) 에어로졸 약물 전달을 위한 조성물, 방법 및 시스템
CN103052378A (zh) 包含磷酸二酯酶抑制剂的药物制剂
JP2016519160A (ja) 3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム
Kaur et al. Advanced aerosol delivery devices for potential cure of acute and chronic diseases
WO2021033081A1 (en) Stable aerosol composition for inhalation comprising glycopyrronium, formoterol and corticosteroid
JP2004529108A (ja) R−サルメテロールおよびプロピオン酸フルチカゾンを含んでなる医薬製剤
HK40087057A (en) Device for treating anaphylaxis
HK40087057B (en) Device for treating anaphylaxis
WO2025072756A1 (en) Device, methods, and uses for treating acute allergic reactions
US20100291221A1 (en) Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
HK40102631A (zh) 用於治疗过敏反应的装置
EP2827877B1 (en) Uses of antagonists of hyaluronan signaling
JP2024533453A (ja) 送達デバイスおよび組成物
CN118414148A (zh) 用于气溶胶药物递送的组合物、方法和系统
EP2429297A1 (en) Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation